InnoRx Pharmaceuticals, a Mobile company built around an implant that delivers drugs inside the eye for more than a year, has been acquired by Minnesota-based SurModics in a cash-and-stock deal valued at $38.7 million.
InnoRx Pharmaceuticals, a Mobile company built around an implant that delivers drugs inside the eye for more than a year, has been acquired by Minnesota-based SurModics in a cash-and-stock deal valued at $38.7 million.